Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and...

  • Main
  • 2019 / 10
  • Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and...

Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients

Hoshikawa, Kohei, Naito, Takafumi, Akutsu, Shunta, Saotome, Masao, Maekawa, Yuichiro, Kawakami, Junichi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Basic & Clinical Pharmacology & Toxicology
DOI:
10.1111/bcpt.13355
Date:
October, 2019
File:
PDF, 20.68 MB
english, 2019
Conversion to is in progress
Conversion to is failed